AstraZeneca vaccine less effective against S.African strain - study

A study released Sunday indicates that the Oxford/AstraZeneca vaccine offers reduced efficacy against the South African variant of the coronavirus. Researchers reported that the vaccine does not prevent mild and moderate cases of this particular strain